Christine B.
- Country
- France
- Department
- Dermatologie
Research Overview
- A double-blind, randomized, placebo-controlled, interventional, multicenter, phase III clinical trial to investigate the safety and efficacy of ABCB5-positive mesenchymal stromal cells (ABCB5+ MSCs) on epidermolysis bullosa (EB)
- Evaluation of Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Amlitelimab in Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
- Evaluation of Safety and Efficacy of Topical SXR1096 Cream in Patients with Netherton Syndrome: A Phase I/II Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 94 of 173 partner sites.
Specializations
Dermatological Disorders
This investigator specializes in treating complex atopic dermatitis, with particular focus on moderate to severe cases requiring advanced therapeutic interventions.
- Atopic Dermatitis Management
- Long-term Treatment Approaches
- Biologic Therapy Response
Extensive work in evaluating novel treatment options for patients who have had inadequate responses to conventional therapies.
Genetic Skin Conditions
Specialized expertise in rare genetic skin disorders, particularly epidermolysis bullosa in its various forms, including recessive dystrophic and junctional subtypes.
- Epidermolysis Bullosa Treatment
- Wound Healing Therapeutics
- Genetic Skin Disease Management
Focus on developing therapeutic approaches for both pediatric and adult patients with genetic skin conditions.
Rare Skin Disorders
Expertise in treating rare dermatological conditions including Netherton syndrome and X-linked hypohidrotic ectodermal dysplasia.
- Severe Erythema Multiforme
- Developmental Skin Disorders
- Novel Therapeutic Applications
Dedicated to advancing treatment options for rare and complex dermatological conditions through innovative therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.